Adipose-derived stem cells (ASCs) have been extensively investigated for their mesenchymal differentiation, transdifferentiation, paracrine effects, immune modulation, and clinical implications for regenerative medicine.1,2 However, recent studies have indicated that stromal vascular fraction (SVF) also possesses similar potential for regenerative medicine and clinical implications.3–10 Some investigators suggested that SVF may even have an advantage over ASCs because of the presence of endothelial progenitor cells, pericytes, immune cells, and other stromal components along with the ASCs.3 SVF cells are relatively easy and quick to obtain in large quantities without the need of a process of cell culture; therefore, both liposuction and SVF transplantation procedures can be accomplished at same day.
A number of animal studies11–17 and human clinical trials18,19 have demonstrated that intraarterial infusion is a safe and effective route for the delivery of bone marrow-derived mesenchymal stromal cells (MSCs) to the targeted tissues at a distance for the treatment of stroke,12,14,16,18 myocardial infarction,15,19 renal failure,13 femoral head necrosis,11 and so on. In contrast, several animal studies20–24 have reported that intraarterial infusion of MSCs in the settings of xenogeneic or allogeneic transplantations compromised blood flow and caused microembolisms and vascular obstruction.
A number of reports have stated that ASCs and SVF are safe, efficacious, and carry relatively low rates of morbidity and side effects; however, in most cases, ASCs or SVF were administrated by in situ injection or topical applications.1–10 It is unclear whether ASCs or SVF can be delivered through a systemic route such as intraarterial infusion. Intraarterial cell delivery could enhance the homing efficiency to the targeted organs at distance such as heart and brain. The purpose of this study was to examine the microcirculatory responses in vivo on local intraarterial infusion of autogenic ASCs or SVF in a vascular pedicle isolated rat cremaster microcirculation model and to determine whether intraarterial infusion is an appropriate route for the delivery of autogenic ASCs or SVF.
All experimental procedures involving the care of the animals were approved by our Institutional Animal Care and Use Committee. Male Sprague–Dawley rats weighing 120–160 g were used. Anesthesia was accomplished using intraperitoneal sodium pentobarbital (50 mg/kg). Fat tissue was surgically harvested from rat bilateral flanks, carefully minced with scissors, and then processed for the enzymatic isolation of SVF.
Isolation of Stromal Vascular Fraction
The method of SVF isolation has been described in our previous publication.25–30 Briefly, the fat tissue was washed with phosphate-buffered saline (PBS) and then centrifuged at 430g for 10 minutes. After oil removal, the lipid phase of fat from the top of the conical tube was harvested and then diluted with an equal volume of collagenase digestion solution (final concentration: 0.3 U/mL, Collagenase NB 4G proved grade, Serva Electrophoresis, Heidelberg, Germany). After 30 minutes of incubation, an equal volume of Dulbecco’s Modified Eagle medium containing 20% fetal bovine serum was added to stop enzymatic digestion. The floating layer containing adipocytes and the pellet containing SVF were separated by centrifugation. The isolated SVF was filtered first through a 100-µm and then a 20-µm nylon filter. Total number of SVF cells was counted. The cell size of SVF was measured by a stage micrometer (Meiji Techno, Japan) under the microscope in each sample before they are used for intraarterial infusion.
Purification of ASC through SVF Culture
SVF is highly heterogeneous and contains many cell subsets including ASCs, blood cells, endothelial cell, pericytes, T cells, B cells, mast cells, and macrophages. One of the unique characteristics of ASC is that they are adherent to the plastic surface. Therefore, the isolation of purified ASC can be achieved through SVF culture. The method for ASC culture has been described in our previous publication.25–30 In brief, all the isolated SVF cells were added into a 75-cm2 cell culture flask containing 15 mL of prewarm Nonhematopoietic Expansion Medium (Miltenyi Biotec, Auburn, Calif.) and 1% of penicillin–streptomycin. The flask was cultivated at 37°C, 5% CO2, and 95% humidity. After 24 hours of culture, the nonadherent cells in the flask were removed by PBS washing. Trypsin/EDTA 1 mL was added into the flask and incubated at 37°C for 10 minutes. After complete dissociation, the total number of ASCs was harvested and counted. The cell size of ASCs was measured by a stage micrometer under the microscope in each sample before they are be used for intraarterial infusion.
Vascular Pedicle Isolated Rat Cremaster Model
Vascular pedicle isolated rat cremaster model is a microcirculation model which has been used by the principle investigator for more than 20 years (Fig. 1).31–36 Briefly, the vascular pedicle, consisting of the pubic-epigastria vessels, was dissected free up to the iliac vessels. A 2-cm-long segment of iliac artery distal and proximal to the pedicle was completely freed from the correspondent veins under the surgical microscope. All other branches arising from iliac and pedicle arteries were ligated to ensure all the infused SVF or ASC cells going nowhere but the cremaster muscle. A tubing (PE-10) presoaked with heparin and filled with saline was cannulated through femoral artery and the end of tubing was secured at 0.5 cm distal to the vascular pedicle of the cremaster muscle (Fig. 1). After surgical preparation, the cremaster muscle was carefully spread on a glass slide and covered with gas-impermeable plastic film. This preparation was then placed on the stage of a trinocular microscope (Olympus, Tokyo, Japan) equipped with an NEC, NC-8 CCD video camera (NEC, Tokyo, Japan). The video image was observed in real time on the monitor, transferred by Pinnacle Video Transfer, and recorded on a USB 2.0 mass storage device. Body and muscle temperatures of rats were maintained at 36–37 and 30–32°C, respectively, using regulated heat lamps.
Arteriole Diameter and Capillary Density Measurement
The method used to measure arteriole diameter and capillary density was described in our previous publications.31–36 Briefly, the images of the vascular tree in the cremaster muscle were systematically scanned from the major feeding arteriole (A1: 100–160 µm) down to the middle arterioles (A2: 40–80 µm) and the terminal arterioles (A3–A4: 10–30 µm). Baseline diameter measurements were obtained for every segment of the visible arteriole tree between each branching point. Inside diameter of each vessel at the narrowest part of each segment was measured. Two locations in the cremaster muscle were observed to determine capillary density. At each location, 9 adjacent fields of view were identified and 18 capillary fields were counted in each muscle. The same arterioles and capillary fields were reexamined during the infusion of SVF or ASC. Results are expressed as the average number of flowing capillaries/field in each cremaster muscle.
After fat tissue harvesting from rat’s bilateral flanks, wounds were closed by 5-o sutures. Fat tissue was then processed for SVF isolation. During the cell process, the vascular pedicle isolated rat cremaster model was prepared. After the baseline measurement of arteriole diameter and capillary density in the cremaster muscle, the freshly isolated autogenic SVF (1 × 105) cells (n = 6) were diluted in 1 mL of normal saline (prewarmed to 37°C) and then infused into the microcirculation of cremaster muscle at a speed from 0.05 mL/min through the cannulated femoral artery. The microcirculatory response in vivo to local intraarteriole infusion of SVF was measured in real time at 5 minutes during SVF infusion.
The protocol for ASC intraarterial infusion was slightly different from the protocol of SVF infusion. After the procedure of fat tissue harvesting, rat was moved back to the cage for recovery from anesthesia. Fat tissue was processed for the isolation of SVF. The isolated SVF was then cultured for 24 hours for the purification of ASCs. On day 2, the same rat was anesthetized again for the preparation of the vascular pedicle isolated rat cremaster preparation. The purified autogenic ASC (1 × 105) cells (n = 6) were dissolved in 1 mL of normal saline and then infused into the microcirculation of cremaster muscle at a speed from 0.05 mL/min through the cannulated femoral artery. The microcirculatory response in vivo to local intraarteriole infusion of ASCs was measured in real time at 5 minutes during ASC infusion.
All measurements were compared by using analysis of variance followed by t test. A value of P ≤ 0.05 was considered significant.
In each cremaster muscle, 2 of A1 arterioles, 4 of A2 arterioles, 9 of A3/A4 arterioles, and 18 of capillary fields were measured. During the initial baseline period, all vessels and capillaries displayed vigorous blood flow and typical diameters. Before infusion, the cell sizes of SVF and ASC were measured. The average cell size was 17.0 ± 0.7 and 19.8 ± 0.7 µm for SVF and ASC, respectively.
In this study, the first 2 minutes of infusate was actually saline, which was preloaded in the PE-10 tubing. Microcirculation including arteriole diameter and capillary perfusion was observed during saline infusion. No significant microcirculation alteration was found during saline infusion which was corresponded with the findings from our previous studies.31,32,36
There was a significant increase on the diameter of terminal arterioles (A3/A4) and the capillary density during ASC intraarterial infusion. The average diameter (mean ± SEM) during ASC infusion was 95.9% ± 2.4% in A1, 99.8% ± 1.4% in A2, and 113.2% ± 2.8% in A3/A4 (P = 0.049) as compared to the baseline. The average capillary density was 110.2% ± 1.9% (P = 0.02) as compared to the baseline (Fig. 2). Great attention has been paid to the terminal arterioles and capillary perfusion at the time of ASC infusion because the size of ASC is similar to the diameter of the vessels. No ASC trapping-induced microcirculatory alterations were seen. No microembolisms and microcirculation obstruction were found at the time of ASC infusion. After 10 minutes of ASC infusion, a bolus injection was tested. Even when a gentle bolus injection was made with the remaining ASC solution, the microcirculation was quickly returned to normal status within a few seconds.
However, there was a significant change in the blood flow, arteriole diameter, and capillary density during SVF intra-arterial infusion. As soon as the SVF solution entered the blood vessel, a significant cell aggregation was detected in the arteriole tree. Microembolisms were often flowing within the blood stream or sticking on the arteriole wall with vasoconstriction. (See video, Supplemental Digital Content 1, which displays SVF intra-arterial infusion. Microembolisms were flowing within blood stream or sticking on the arteriole wall (A1) with vasoconstriction. This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A272.) Embolisms that are narrowing or blocking the lumen of A3 or A4 arterioles can be found in many places resulting in no flow in the corresponding capillaries. The average diameter was 69.9% ± 3.0% in A1, 60.4% ± 2.6% in A2, and 60.4% ± 1.2% in A3/A4 as compared to the baseline and ASC group (P < 0.01 in all sizes of arterioles). The capillary density was 43.3% ± 4.0% as compared to the baseline and ASC group (P < 0.01). After 10 minutes of SVF infusion, a bolus injection was tested. The bolus injection of SVF solution accelerated embolisms accumulation at the bifurcation of A1 and A2 arterioles resulting in no flow in entire cremaster muscle. (See video, Supplemental Digital Content 2, which displays SVF intra-arterial bolus injection. This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A273.)
A number of animal studies11–17 and human clinical trials18,19 have demonstrated that bone marrow-derived MSCs can be delivered systemically through an intra-arterial infusion. For example, Jin et al11 reported the intra-arterial infusion of autologous MSCs as a feasible and relatively safe method for the treatment of femoral head necrosis in dog model. Silachev et al12 found that the intra-arterial injection of MSCs to the brain through the carotid arteries substantially promoted functional recovery after traumatic brain injury. Katsuoka et al13 showed that intra-arterial catheter system was effective in delivering MSCs to the kidney and permitted repeated injection of cells. Fukuda et al14 described that intra-arterial transplantation of low-dose (1 × 104 cells) MSCs provided functional recovery without adverse effects after ischemic stroke in a rat model. De Jong et al15 reported that intracoronary infusion of encapsulated glucagon-like peptide-1-eluting MSCs preserved left ventricular function in a porcine model of acute myocardial infarction. In a prospective, nonrandomized, open-label, phase I human study, Banerjee et al18 stated that the autologous CD34+ MSCs can be safely delivered to the infarct territory through intra-arterial injection in the patients with acute ischemic stroke. All patients showed improvements in clinical functional scores and reductions in lesion volume during a 6-month follow-up period. On the contrary, several studies20–24 reported that the intra-arterial MSCs delivery could compromise blood flow and cause microembolisms and vascular obstruction. However, through the literature review, it was found that most of these studies were in either human-to-rat20,21 or Lewis-to-Wistar rats22,23 transplantations. It is understandable in the cases of xenogeneic or allogeneic transplantations that when the cells were transplanted to a recipient from a genetically nonidentical donor, the recipient’s immune system and complement could be activated to stimulate coagulation and embolism formation.
Compared to the intra-arterial MSC delivery, there are very limited reports on intra-arterial ASC delivery. Jiang et al37 found that intracarotid injection of autologous ASCs provided significant protection against ischemic stroke in rats. Hong et al38 examined intracoronary infusion of autologous ASCs in swine myocardial infarction model and found the evidence of ASCs trapping in the microcirculation at higher doses (50 × 106) of ASC infusion. So far, there is no report on intra-arterial SVF delivery.
The purpose of this study was to examine the microcirculatory responses in real time in vivo on local intra-arterial infusion of autogenic ASCs or SVF in a vascular pedicle isolated rat cremaster microcirculation model and to determine whether intra-arterial infusion is an appropriate route for the delivery of autogenic ASCs or SVF. Here, the point of emphasis is that this was a local intra-arterial infusion rather than a systemic intra-arterial infusion. In a systemic infusion model, multiple concentrations and infusion speeds can be examined. Although higher concentrations of cell can be administrated to the whole body in systemic infusion model, the actual number of cells entering into the target tissue of interest (such as cremaster) could be very limited and is difficult to be quantitated. However, for this local intra-arterial infusion with our unique preparation, all the vascular branches arising from pedicle artery were ligated to ensure all the cells going nowhere but the cremaster. Therefore, it is possible to determine how many cells were administered into the cremaster in the limited time period. Moreover, the size of the rat cremaster is comparable to the size of human thumb tip and paper thin. If such a small piece of tissue can sustain 1 × 105 cells infusion without causing microcirculation obstruction, then systemic infusion at any reasonable higher concentrations should be possible.
The cell size, concentration, and infusion speed are not considered responsible for SVF-induced microcirculatory obstruction because no embolisms and no microcirculatory obstruction were found during infusion of ASCs that have the same cell size, concentration, and infusion speed as SVF. A great attention has been paid to observe the A3/A4 terminal arterioles. No significant cell trapping was seen in the terminal arterioles during ASC or SVF infusion. On the contrary, many microembolisms flowing from proximal to distal (from A1 to A4) and then narrowing or blocking the lumen of terminal arterioles during SVF infusion were seen. The normal blood flow in the feeding arteriole (A1) of cremaster is about 220 nL/s.39 This infusion speed was used to study ischemia and reperfusion injury for more than 20 years.31–36 As this is a microcirculation study, no significant change in infusion speed was made because it could alter microcirculatory dynamics and physiology.
Moreover, the bolus injection was used to deliver bone marrow-derived MSCs to animals and human in clinical trials.18,19 However, this method is not appropriate for a microcirculation study presented here because it could mechanically alter the microcirculatory dynamics and physiology. Therefore, the bolus injection was not even planned in the experimental protocol and the bolus-injection-induced microcirculatory response was not intended to be measured. For the curiosity, however, after the completion of the planned experiments, a gentle bolus injection was tested by using the remaining ASC or SVF solution. A significant vasodilatation was observed immediately after gentle bolus injection; however, arteriole diameter was quickly returned to normal status within a few seconds.
The mechanism of ASC-induced vasodilation in the terminal arterioles is unclear. However, based on our previous study,29 it was hypothesized that the ASC-induced vasodilation in terminal arterioles could be due to the growth factors such as vascular endothelial growth factor produced by ASCs. It is unknown why the intra-arterial infusion of autogenic SVF, but not autogenic ASC, caused rapid cell aggregation with microembolisms formation. Compared to the purified ASC, SVF is a heterogeneous collection of cells that include ASCs, blood cells, endothelial progenitor cell, pericytes, T cells, B cells, mast cells, and macrophages. Dr. Wang has interpreted that some components in the SVF cells isolated from adipose tissue might not be compatible with the blood components that might result in blood coagulation and embolism formation. Nevertheless, a further study is definitely warranted to explore the mechanism for this autogenic SVF-induced embolism formation.
Intra-arterial infusion is an appropriate route for delivery of autogenic ASCs, but not of SVF. SVF-induced microembolisms were the cause that narrowing or blocking the lumen of terminal arterioles resulting in no-flow in the corresponding capillaries.
1. Feisst V, Meidinger S, Locke MB. From bench to bedside: use of human adipose-derived stem cells. Stem Cells Cloning 2015;8:149162.
2. Uzbas F, May ID, Parisi AM, et al. Molecular physiognomies and applications of adipose-derived stem cells. Stem Cell Rev. 2015;11:298308.
3. Nguyen A, Guo J, Banyard DA, et al. Stromal vascular fraction: a regenerative reality? Part 1: current concepts and review of the literature. J Plast Reconstr Aesth Surg. 2015;69:170179.
4. Guo J, Nguyen A, Banyard DA, et al. Stromal vascular fraction: a regenerative reality? Part 2: mechanisms of regenerative action. J Plast Reconstr Aesth Surg. 2015;69:180188.
5. Michalek J, Moster R, Lukac L, et al. Autologous adipose tissue-derived stromal vascular fraction cells application in patients with osteoarthritis. Cell Transplant. 2015 [Epub ahead of print].
6. Wittmann K, Dietl S, Ludwig N, et al. Engineering vascularized adipose tissue using the stromal-vascular fraction and fibrin hydrogels. Tissue Eng A. 2015;21:13431353.
7. Jang Y, Koh YG, Choi YJ, et al. Characterization of adipose tissue-derived stromal vascular fraction for clinical application to cartilage regeneration. In Vitro Cell Dev Biol Anim. 2015;51:142150.
8. Behfar M, Javanmardi S, Sarrafzadeh-Rezaei F. Comparative study on functional effects of allotransplantation of bone marrow stromal cells and adipose derived stromal vascular fraction on tendon repair: a biomechanical study in rabbits. Cell J. 2014;16:263270.
9. Atalay S, Coruh A, Deniz K. Stromal vascular fraction improves deep partial thickness burn wound healing. Burns 2014;40:13751383.
10. Granel B, Daumas A, Jouve E, et al. Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis. 2015;74:21752182.
11. Jin H, Xu T, Chen Q, et al. The fate and distribution of autologous bone marrow mesenchymal stem cells with intra-arterial infusion in osteonecrosis of the femoral head in dogs. Stem Cells Int. 2016. Epub 2015 Dec 8.
12. Silachev DN, Plotnikov EY, Babenko VA, et al. Intra-arterial administration of multipotent mesenchymal stromal cells promotes functional recovery of the brain after traumatic brain injury. Bull Exp Biol Med. 2015;159:528533.
13. Katsuoka Y, Ohta H, Fujimoto E, et al. Intra-arterial catheter system to repeatedly deliver mesenchymal stem cells in a rat renal failure model. Clin Exp Nephrol. 2016;20:169177.
14. Fukuda Y, Horie N, Satoh K, et al. Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke. Cell Mol Neurobiol. 2015;35:399406.
15. De Jong R, Van Hout GP, Houtgraaf JH, et al. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction. Circ Cardiovasc Interv. 2014;7:673683.
16. Yavagal DR, Lin B, Raval AP, et al. Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. PLoS One 2014;9: e93735.
17. Mäkelä T, Takalo R, Arvola O, et al. Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model. Cytotherapy 2015;17:392402.
18. Banerjee S, Bentley P, Hamady M, et al. Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke. Stem Cells Transl Med. 2014;3:13221330.
19. De Jong R, Houtgraaf JH, Samiei S, et al. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovasc Interv. 2014;7:156167.
20. Janowski M, Lyczek A, Engels C, et al. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab. 2013;33:921927.
21. Ge J, Guo L, Wang S, et al. The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev. 2014;10:295303.
22. Cui LL, Kerkelä E, Bakreen A, et al. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther. 2015;6:11.
23. Toma C, Wagner WR, Bowry S, et al. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res. 2009;104:398402.
24. Vulliet PR, Greeley M, Halloran SM, et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004;363:783784.
25. Wang WZ, Fang XH, Williams SJ, et al. Analysis for apoptosis and necrosis on adipocytes, stromal vascular fraction, and adipose-derived stem cells in human lipoaspirates after liposuction. Plast Reconstr Surg. 2013;131:77e85e.
26. Wang WZ, Fang XH, Stephenson LL, et al. The effect of lipoaspirates cryopreservation on adipose-derived stem cells. Aesth Surg J. 2013;33:10461055.
27. Wang WZ, Fang XH, Williams SL, et al. Lidocaine-induced ASC apoptosis (tumescent vs local anesthesia). Aesth Plast Surg. 2014;38:10171023.
28. Wang WZ, Fang XH, Stephenson LL, et al. The impact of short-term refrigeration of lipoaspirate on adipose-derived stem cells and adipocytes. J Plast Reconstr Aesth Surg. 2015;68:137139.
29. Wang WZ, Fang XH, Williams SJ, et al. Elimination of reperfusion-induced microcirculatory alterations in vivo
by adipose-derived stem cell supernatant without adipose-derived stem cells. Plast Reconstr Surg. 2015;135:10561064.
30. Goodman JJ, Wang WZ, Fang XH, et al. Tumescent liposuction without lidocaine. Plast Reconstr Surg. In Press.
31. Wang WZ, Anderson G, Fleming JT, et al. Lack of nitric oxide contributes to vasospasm during ischemia/reperfusion injury. Plast Reconstr Surg. 1997;99:10991108.
32. Wang WZ, Fang XH, Stepheson LL, et al. Acute microvascular action of vascular endothelial growth factor in skeletal muscle ischemia/reperfusion injury. Plast Reconstr Surg. 2005;115:13551365.
33. Wang WZ, Fang XH, Stephenson LL, et al. Microcirculatory effects of melatonin in rat skeletal muscle after prolonged ischemia. J Pineal Res. 2005;39:5765.
34. Wang WZ, Fang XH, Stephenson LL, et al. Melatonin reduces I/R-induced superoxide generation in arterial wall and cell death in skeletal muscle. J Pineal Res. 2006;41:255260.
35. Wang WZ, Fang XH, Stephenson LL, et al. Ischemia-reperfusion-induced apoptotic endothelial cells isolated from rat skeletal muscle. Plast Reconstr Surg. 2009;123(2 Suppl):131S138S.
36. Wang WZ, Fang XH, Stephenson LL, et al. Nitrite attenuates I/R-induced microcirculatory alterations and mitochondrial dysfunction in the microvasculature of skeletal muscle. Plast Reconstr Surg. 2011;128:279e287e.
37. Jiang W, Liang G, Li X, et al. Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAo. J Mater Sci Mater Med. 2014;25:13571366.
38. Hong SJ, Hou D, Brinton TJ, et al. Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution. Catheter Cardiovasc Interv. 2014;83: E17E25.
39. Meininger GA. Responses of sequentially branching macro- and microvessels during reactive hyperemia in skeletal muscle. Microvasc Res. 1987;34:2945.
Supplemental Digital Content
Copyright © 2016 The Author. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved.